| Typicality: | 0.495 |
| Saliency: | 0.423 |
| orally | 10 | manner |
| intravenously | 8 | manner |
| twice daily | 6 | temporal |
| product → be → administered | 144 |
| product → be administered in → way | 3 |
| negative | neutral | positive |
| 0.178 | 0.676 | 0.146 |
| Raw frequency | 147 |
| Normalized frequency | 0.423 |
| Modifier score | 0.700 |
| Perplexity | 374.357 |